Case Report
Published on 11 Jul 2022
A Dramatic Response to Toripalimab With Chemotherapy and Antiangiogenic Agent Followed by Surgery in a Stage IIIB Lung Adenocarcinoma Patient With an Uncommon EGFR Mutation: A Case Report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2022.915628
- 2,478 views
- 1 citation

